Literature DB >> 27363881

Practice Gaps in Pruritus.

Jonathan I Silverberg1.   

Abstract

There are several practice gaps in the evaluation and management of itch. These gaps include a dearth of objective measures of itch, infrequent use of validated patient-reported outcomes for itch, non-evidence-based treatment, and lack of consensus about the ideal workup for generalized itch. The present article reviews these gaps and presents potential solutions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assessment; Education; Itch; Pruritus; Treatment; Workup

Mesh:

Year:  2016        PMID: 27363881      PMCID: PMC5216168          DOI: 10.1016/j.det.2016.02.008

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  26 in total

1.  The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies.

Authors:  Sophie Grand'Maison; Madeleine Durand; Michèle Mahone
Journal:  J Obstet Gynaecol Can       Date:  2014-07

2.  Are subjective accounts of itch to be relied on? The lack of relation between visual analogue itch scores and actigraphic measures of scratch.

Authors:  Caroline S Murray; Jonathan L Rees
Journal:  Acta Derm Venereol       Date:  2011-01       Impact factor: 4.437

3.  Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus.

Authors:  Ngoc Quan Phan; Christine Blome; Fleur Fritz; Joachim Gerss; Adam Reich; Toshiya Ebata; Matthias Augustin; Jacek C Szepietowski; Sonja Ständer
Journal:  Acta Derm Venereol       Date:  2012-09       Impact factor: 4.437

Review 4.  Pruritus in the older patient: a clinical review.

Authors:  Timothy G Berger; Melissa Shive; G Michael Harper
Journal:  JAMA       Date:  2013-12-11       Impact factor: 56.272

5.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Timothy G Berger; Alfons Krol; Amy S Paller; Kathryn Schwarzenberger; James N Bergman; Sarah L Chamlin; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; David J Margolis; Robert A Silverman; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527

6.  Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.

Authors:  Yalcin Solak; Zeynep Biyik; Huseyin Atalay; Abduzhappar Gaipov; Figen Guney; Suleyman Turk; Adrian Covic; David Goldsmith; Mehmet Kanbay
Journal:  Nephrology (Carlton)       Date:  2012-11       Impact factor: 2.506

Review 7.  Epidemiology of itch: adding to the burden of skin morbidity.

Authors:  Elke Weisshaar; Florence Dalgard
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

Review 8.  Pruritus in burns: review article.

Authors:  Ioannis Goutos; Peter Dziewulski; Patricia M Richardson
Journal:  J Burn Care Res       Date:  2009 Mar-Apr       Impact factor: 1.845

Review 9.  An evidence-based review of systemic treatments for itch.

Authors:  P Pongcharoen; A B Fleischer
Journal:  Eur J Pain       Date:  2015-09-28       Impact factor: 3.931

10.  Effect of the pruritus on the quality of life: a preliminary study.

Authors:  Irem Eren Erturk; Ozer Arican; Imran Kurt Omurlu; Necdet Sut
Journal:  Ann Dermatol       Date:  2012-11-08       Impact factor: 1.444

View more
  1 in total

1.  A Comprehensive Conceptual Model of the Experience of Chronic Itch in Adults.

Authors:  Jonathan I Silverberg; Robert W Kantor; Prarthana Dalal; Catherine Hickey; Sara Shaunfield; Karen Kaiser; Jin-Shei Lai; David Cella
Journal:  Am J Clin Dermatol       Date:  2018-10       Impact factor: 7.403

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.